HEMAGGLUTININ, CHAIN HA1
Influenza A virus
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Other combination Homooligomer Protein × 6 其他Polymer 9 PDB declaration: hexameric(6) Consistent with protein copy count | Chain A; UniProt 17–344 Chain B; UniProt 346–520 Chain C; UniProt 17–344 Chain D; UniProt 346–520 Chain E; UniProt 17–344 Chain F; UniProt 346–520 | Not recorded | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 3 N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose-(1-4)-beta-D-glucopyranose × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 | X-RAY DIFFRACTION mmCIF provides none of the parsed experimental conditions | Resolution 2.90 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1HGG | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1EO8 INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY Deposited 2000-03-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
17–344(328 aa)
Fragment:BROMELAIN RELEASED FRAGMENT
Chain B
346–520(175 aa)
Fragment:BROMELAIN RELEASED FRAGMENT
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;28%(w:v) PEG 600, 100 mM Sodium Phosphate, 150 mM NaCl, 0.05% NaN3 , pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.80 Å R-free 0.298 |
| 1FYT CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 Deposited 2000-10-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
322–334(13 aa)
Fragment:ANTIGEN PEPTIDE
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;11% PEG 8000, 1 M NaCl, 100 mM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 18K
|
Resolution 2.60 Å R-free 0.255 |
| 1HA0 HEMAGGLUTININ PRECURSOR HA0 Deposited 1998-10-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
25–518(494 aa)
Fragment:HA1, HA2
|
Mutation:R329Q | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;pH 7.50
|
Resolution 2.80 Å R-free 0.302 |
| 1HGD BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY Deposited 1991-11-01 | Different oligomeric state Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.70 Å |
| 1HGE BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY Deposited 1991-11-01 | Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 MNA 2-O-methyl-5-N-acetyl-alpha-D-neuraminic acid × 3 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.60 Å |
| 1HGF BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY Deposited 1991-11-01 | Different oligomeric state Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.00 Å |
| 1HGH BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY Deposited 1991-11-01 | Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 MNA 2-O-methyl-5-N-acetyl-alpha-D-neuraminic acid × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.70 Å |
| 1HGI BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY Deposited 1991-11-01 | Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ANA methyl 4-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid × 3 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.70 Å |
| 1HGJ BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY Deposited 1991-11-01 | Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 AMN methyl 5-acetamido-9-amino-3,5,9-trideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid × 3 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.70 Å |
| 1HTM STRUCTURE OF INFLUENZA HAEMAGGLUTININ AT THE PH OF MEMBRANE FUSION Deposited 1994-11-02 | Different construct Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–43(27 aa)
Chain B
383–520(138 aa)
Chain C
17–43(27 aa)
Chain D
383–520(138 aa)
Chain E
17–43(27 aa)
Chain F
383–520(138 aa)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.50 Å R-free 0.291 |
| 1J8H Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide, and MHC Class II Molecule, HLA-DR4 Deposited 2001-05-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
322–334(13 aa)
Fragment:Antigen Peptide
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;13% PEG 8000, 1 M NaCl, 100 mM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.40 Å R-free 0.246 |
| 1KEN INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION Deposited 2001-11-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric |
Chain B
346–520(175 aa)
Fragment:FAB fragment of antibody
Chain D
346–520(175 aa)
Fragment:FAB fragment of antibody
Chain F
346–520(175 aa)
Fragment:FAB fragment of antibody
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;peg 20000, calcium chloride, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.50 Å R-free 0.323 |
| 1QFU INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY Deposited 1999-04-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
17–344(328 aa)
Fragment:BROMELAIN DIGESTED
Chain B
346–520(175 aa)
Fragment:BROMELAIN DIGESTED
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.0
|
Resolution 2.80 Å R-free 0.284 |
| 1QU1 CRYSTAL STRUCTURE OF EHA2 (23-185) Deposited 1999-07-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
376–530(155 aa)
Chain B
376–530(155 aa)
Chain C
376–530(155 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.4;2% PEG 4000, 30-150 MM NACL, pH 4.40
|
Resolution 1.90 Å R-free 0.250 |
| 1QU1 CRYSTAL STRUCTURE OF EHA2 (23-185) Deposited 1999-07-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain D
376–530(155 aa)
Chain E
376–530(155 aa)
Chain F
376–530(155 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.4;2% PEG 4000, 30-150 MM NACL, pH 4.40
|
Resolution 1.90 Å R-free 0.250 |
| 2HMG REFINEMENT OF THE INFLUENZA VIRUS HEMAGGLUTININ BY SIMULATED ANNEALING Deposited 1989-09-11 | Different oligomeric state Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.00 Å |
| 2VIR INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY Deposited 1997-12-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
44–325(282 aa)
Fragment:;PROTEOLYTIC FRAGMENT "HA TOP" CONTAINING HA1 RESIDUES 28 - 328
;
|
Not recorded | ZN ZINC ION × 3 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.25 Å R-free 0.249 |
| 2VIS INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY Deposited 1997-12-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
44–325(282 aa)
Fragment:;PROTEOLYTIC FRAGMENT "HA TOP" CONTAINING HA1 RESIDUES 28 - 328
;
|
Mutation:T131I | ZN ZINC ION × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.25 Å R-free 0.267 |
| 2VIT INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY Deposited 1997-12-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
44–325(282 aa)
Fragment:;PROTEOLYTIC FRAGMENT "HA TOP" CONTAINING HA1 RESIDUES 28 - 328
;
|
Mutation:T155I | ZN ZINC ION × 3 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.25 Å R-free 0.237 |
| 2VIU INFLUENZA VIRUS HEMAGGLUTININ Deposited 1997-12-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
|
Mutation:CHAIN A, T131I Mutation:CHAIN A, T131I | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.50 Å R-free 0.242 |
| 2YPG Haemagglutinin of 1968 Human H3N2 Virus in Complex with Human Receptor Analogue LSTc Deposited 2012-10-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Fragment:HA2 OF BROMELAIN RELEASED ECTODOMAIN, RESIDUES 346-520
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Fragment:HA2 OF BROMELAIN RELEASED ECTODOMAIN, RESIDUES 346-520
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
Fragment:HA2 OF BROMELAIN RELEASED ECTODOMAIN, RESIDUES 346-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 FLC CITRATE ANION × 13 |
X-RAY DIFFRACTION
X-ray crystallization conditions
1.7-2 M TRIAMMONIUM CITRATE PH 6.5
|
Resolution 2.85 Å R-free 0.190 |
| 3EYM Structure of Influenza Haemagglutinin in complex with an inhibitor of membrane fusion Deposited 2008-10-21 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
25–345(321 aa)
Chain B
346–517(172 aa)
Chain C
25–345(321 aa)
Chain D
346–517(172 aa)
Chain E
25–345(321 aa)
Chain F
346–517(172 aa)
|
Not recorded | EYK 2-tert-butylbenzene-1,4-diol × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;Ammonium citratre, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.80 Å R-free 0.217 |
| 3HMG REFINEMENT OF THE INFLUENZA VIRUS HEMAGGLUTININ BY SIMULATED ANNEALING Deposited 1989-09-11 | Different oligomeric state | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 3VUN Crystal structure of a influenza A virus (A/Aichi/2/1968 H3N2) hemagglutinin in C2 space group. Deposited 2012-07-02 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–345(329 aa)
Chain B
346–520(175 aa)
Chain C
17–345(329 aa)
Chain D
346–520(175 aa)
Chain E
17–345(329 aa)
Chain F
346–520(175 aa)
|
Mutation:G144S, I182V Mutation:E132D Mutation:G144S, I182V Mutation:E132D Mutation:G144S, I182V Mutation:E132D | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.25;293 K;0.2M imidazole (pH 7.0), 27% Jeffamine ED-2001 (pH 7.0), VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.00 Å R-free 0.275 |
| 3ZTJ Structure of influenza A neutralizing antibody selected from cultures of single human plasma cells in complex with human H3 Influenza haemagglutinin. Deposited 2011-07-08 | Different construct Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
17–345(329 aa)
Chain B
346–520(175 aa)
Fragment:RESIDUES 346-520
Chain C
17–345(329 aa)
Chain D
346–520(175 aa)
Fragment:RESIDUES 346-520
Chain E
17–345(329 aa)
Chain F
346–520(175 aa)
Fragment:RESIDUES 346-520
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.41 Å R-free 0.284 |
| 4HMG REFINEMENT OF THE INFLUENZA VIRUS HEMAGGLUTININ BY SIMULATED ANNEALING Deposited 1989-09-11 | Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | SIA N-acetyl-alpha-neuraminic acid × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.00 Å |
| 5HMG REFINEMENT OF THE INFLUENZA VIRUS HEMAGGLUTININ BY SIMULATED ANNEALING Deposited 1989-09-11 | Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
17–344(328 aa)
Chain B
346–520(175 aa)
Chain C
17–344(328 aa)
Chain D
346–520(175 aa)
Chain E
17–344(328 aa)
Chain F
346–520(175 aa)
|
Not recorded | SIA N-acetyl-alpha-neuraminic acid × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.20 Å |
| 5Y2L Crystal structure of a group 2 HA binding antibody AF4H1K1 Fab in complex with the 1968 H3N2 pandemic (H3-AC/68) hemagglutinin Deposited 2017-07-26 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
17–345(329 aa)
Chain B
346–521(176 aa)
Fragment:UNP residues 346-521
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;291 K;0.19 mM CYMAL7, 0.1M HEPES pH 7.5, 40% ployethylene glycol 400
|
Resolution 2.90 Å R-free 0.244 |
| 6E56 Human antibody H2214 in complex with influenza hemagglutinin A/Aichi/2/1968 (X-31) (H3N2) Deposited 2018-07-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain D
53–335(283 aa)
Fragment:head domain (UNP residues 53-335)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ACT ACETATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;291.15 K;100 mM sodium chloride, 100 mM sodium acetate, pH 5.0, 20% w/v PEG2000 MME
|
Resolution 2.00 Å R-free 0.214 |
| 6E56 Human antibody H2214 in complex with influenza hemagglutinin A/Aichi/2/1968 (X-31) (H3N2) Deposited 2018-07-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
53–335(283 aa)
Fragment:head domain (UNP residues 53-335)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ACT ACETATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;291.15 K;100 mM sodium chloride, 100 mM sodium acetate, pH 5.0, 20% w/v PEG2000 MME
|
Resolution 2.00 Å R-free 0.214 |
| 6N5D Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope Deposited 2018-11-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
53–334(282 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;0.2 M sodium bromide, 0.1 M Bis-Tris propane, pH 6.5, 20% w/v PEG3350
|
Resolution 3.00 Å R-free 0.244 |
| 6N5D Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope Deposited 2018-11-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain B
53–334(282 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;0.2 M sodium bromide, 0.1 M Bis-Tris propane, pH 6.5, 20% w/v PEG3350
|
Resolution 3.00 Å R-free 0.244 |
| 6N5D Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope Deposited 2018-11-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain K
53–334(282 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;0.2 M sodium bromide, 0.1 M Bis-Tris propane, pH 6.5, 20% w/v PEG3350
|
Resolution 3.00 Å R-free 0.244 |
| 6N5E Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope Deposited 2018-11-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
53–334(282 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;0.2 M ammonium sulfate, 0.1 M MES, pH 6.5, 20% w/v PEG8000
|
Resolution 3.00 Å R-free 0.287 |
| 6N5E Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope Deposited 2018-11-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain B
53–334(282 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;0.2 M ammonium sulfate, 0.1 M MES, pH 6.5, 20% w/v PEG8000
|
Resolution 3.00 Å R-free 0.287 |
| 6N5E Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope Deposited 2018-11-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
53–334(282 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;0.2 M ammonium sulfate, 0.1 M MES, pH 6.5, 20% w/v PEG8000
|
Resolution 3.00 Å R-free 0.287 |
| 6XPX Human antibody S1V2-51 in complex with the influenza hemagglutinin head domain of A/Aichi/2/1968 (X-31)(H3N2) Deposited 2020-07-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
53–335(283 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 BCN BICINE × 2 GOL GLYCEROL × 7 1PE PENTAETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;291.15 K;0.3 M Magnesium chloride, 25% (w/v) PEG 2000, 15% (w/v) Glycerol, 0.1 M BICINE, pH 9.0
|
Resolution 2.60 Å R-free 0.215 |
| 6Y5G Ectodomain of X-31 Haemagglutinin at pH 8 Deposited 2020-02-25 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
24–341(318 aa)
Chain B
346–517(172 aa)
Chain C
24–341(318 aa)
Chain D
346–517(172 aa)
Chain E
24–341(318 aa)
Chain F
346–517(172 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å |
| 6Y5H Ectodomain of X-31 Haemagglutinin at pH 5 (State I) Deposited 2020-02-25 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
24–341(318 aa)
Chain B
346–517(172 aa)
Chain C
24–341(318 aa)
Chain D
346–517(172 aa)
Chain E
24–341(318 aa)
Chain F
346–517(172 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å |
| 6Y5I Dilated form 1 of X-31 Influenza Haemagglutinin at pH 5 (State II) Deposited 2020-02-25 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
24–341(318 aa)
Chain B
346–517(172 aa)
Chain C
24–341(318 aa)
Chain D
346–517(172 aa)
Chain E
24–341(318 aa)
Chain F
346–517(172 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.50 Å |
| 6Y5J Dilated form 2 of X-31 Influenza Haemagglutinin at pH 5 (State III) Deposited 2020-02-25 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
24–341(318 aa)
Chain B
346–517(172 aa)
Chain C
24–341(318 aa)
Chain D
346–517(172 aa)
Chain E
24–341(318 aa)
Chain F
346–517(172 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.60 Å |
| 6Y5K Extended Intermediate form of X-31 Influenza Haemagglutinin at pH 5 (State IV) Deposited 2020-02-25 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
24–341(318 aa)
Chain B
346–517(172 aa)
Chain C
24–341(318 aa)
Chain D
346–517(172 aa)
Chain E
24–341(318 aa)
Chain F
346–517(172 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.20 Å |
| 6Y5L Signal Subtracted Extended Intermediate form of X-31 Influenza Haemagglutinin at pH 5 (State IV) Deposited 2020-02-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric |
Chain B
346–517(172 aa)
Chain D
346–517(172 aa)
Chain F
346–517(172 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å |
| 7ZJ6 X-31 Hemagglutinin Precursor HA0 at pH 7.5 Deposited 2022-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
17–520(504 aa)
Chain B
17–520(504 aa)
Chain C
17–520(504 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;4s blot
|
Resolution 2.60 Å |
| 7ZJ7 X-31 Hemagglutinin Precursor HA0 at pH 4.8 Deposited 2022-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
17–520(504 aa)
Chain B
17–520(504 aa)
Chain C
17–520(504 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.8
cryo-EM vitrification conditions
Cryogen ETHANE;4s blot
|
Resolution 3.95 Å |
| 7ZJ8 X-31 Hemagglutinin Precursor HA0 at pH 7.5 after reneutralization Deposited 2022-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
17–520(504 aa)
Chain B
17–520(504 aa)
Chain C
17–520(504 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 BOG octyl beta-D-glucopyranoside × 3 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE;4s blot
|
Resolution 3.10 Å |
| 8G5B Influenza A H3N2 X-31 Hemagglutinin in complex with FL-1061 Deposited 2023-02-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain A
53–335(283 aa)
Fragment:head fragment
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å |
| 8PK3 CryoEM reconstruction of hemagglutinin HK68 of Influenza A virus bound to an Affimer reagent Deposited 2023-06-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 9 PDB declaration: nonameric |
Chain D
346–520(175 aa)
Chain E
346–520(175 aa)
Chain F
346–520(175 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
42 other PDB entries and 48 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | HEMA_IAAIC |
| Isoform | — |
| PDB entities | 1, 2 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–328; UniProt 17–344 Author chain C; PDBConstruct 1–328; UniProt 17–344 Author chain E; PDBConstruct 1–328; UniProt 17–344 Author chain B; PDBConstruct 1–175; UniProt 346–520 Author chain D; PDBConstruct 1–175; UniProt 346–520 Author chain F; PDBConstruct 1–175; UniProt 346–520 |